2026 Q1 -tulosraportti
90 päivää sitten
‧35 min
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 25.8. | 5 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 22.5. | ||
2025 Q4 -tulosraportti 24.2. | ||
2025 Q3 -tulosraportti 26.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 20.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
·4 t sittenThe CEO's message Formal start of the project with the customer in Western Asia In May, we announced that our partner, Chematur Engineering, had entered into a binding agreement with a customer in Western Asia regarding the first large-scale PHBV plant based on Bioextrax's patented technology. After the end of the second quarter, the customer made the agreed advance payment. The agreement has thereby entered into force, and Phase 1 – the basic design of the plant – has formally commenced. The work is estimated to take five months, and in parallel, the agreement for Phase 2, which includes detailed design, construction, and commissioning of the factory, is being finalized. Progress in the collaboration with Kemiföretaget Another important step was taken at the end of June, when we reached an agreement with Kemiföretaget – one of the world's three largest chemical companies – on a binding framework agreement. The agreement was signed at the beginning of July, runs for three years with the possibility of extension, and creates a clear structure for joint innovation and commercialization projects within Home & Personal Care. The first project concerns mcl-PHA as a bio-based and biodegradable film former that can replace, for example, silicone in personal care products. The driving force in the application is clear: the EU's restrictions against intentionally added microplastics mean that the industry needs alternatives that both function technically and degrade naturally. Strong interest in sun protection Within cosmetics, the sun protection track, which I wrote about in the previous report, has also been further developed. Our early results indicate that our PHBV has a better enhancing effect on SPF (sun protection factor, solskyddsfaktor) compared to PHA from other players, and this has continued to attract interest. Since the previous report, further dialogues and concrete tests have been initiated with global players. Sunscreen is an application that combines requirements from legislators, large volumes, and good willingness to pay, and we continue to evaluate it together with a growing circle of potential customers. Update on the project with Godisproducenten Regarding the collaboration with Godisproducenten, which aims to replace traditional polymers in chewing gums with biodegradable alternatives, we were recently informed that a major reorganization is underway within Godisproducenten. This, in turn, means that the test panel planned for the second quarter of 2026 has been delayed. Currently, we do not know when the test panel will be carried out. Ongoing production for Lantmännen In the project with Lantmännen, a large part of our work in recent months has focused on getting the entire production system in place – not just the hydrolysis step itself, which is the core of our technology, but also the downstream steps such as separation and drying. This is a prerequisite for being able to produce the quantities of hydrolyzed protein required by the feeding trials, and it has required significant resources to get all parts to work together. That work has now been completed. Our focus is therefore on finalizing production so that the material can proceed to feed mixing and feeding trials, together with Lantmännen. News regarding R&D In parallel with commercial development, we have developed a new technology for the production of PHBV, for which we have submitted a patent application. For natural reasons, we are not going into any details at this time, but we see significant potential in it and will revert when the patent situation allows. Continuously broadening and strengthening our intellectual property portfolio is central to a business model based on out-licensing. Ultimately, it is the patents that constitute the product we sell, and every new application that holds increases the value of what we have to offer future licensees. During the period, we have also installed our own laboratory for strain development and commenced work there. Strain development involves developing and refining the microorganisms that produce our PHA, and this gives us significantly greater flexibility – both to influence the material properties of the PHA produced and to adapt the process parameters in production. This opens up the possibility of meeting specific customer requirements in a way that would otherwise not have been possible. In parallel, we continue to develop our existing production processes based on so-called “wild bacteria”; the new laboratory complements this work, it does not replace it. Lund, August 20, 2026 Edvard Hall Managing Director
·14.8.The company is currently small, has few employees, but has groundbreaking technology. A breakthrough here means contracts that are enormously large in SEK compared to today's market value. The stock is a binary bet currently, where the value might halve if things continue to drag out, but where the upside is 5-10x when concrete agreements come. The first agreement with "Kemi-bolaget" should be right around the corner.Market worth at 100 million then you are relatively cautious with 5x on the upside. I don't think there's much downside either with valuation against market value, probably scraping the bottom. I don't foresee another 50% 7 days before an update on projects. Rather listen to the podcast, However, I'm not all in, only a relatively small position.- ·13.8.https://open.spotify.com/episode/1jlEKFgYJBoZ6zgj9qbrKD https://open.spotify.com/episode/1jlEKFgYJBoZ6zgj9qbrKD New podcast episode with Edward today.
- ·13.8.Today, new rules for the packaging of goods sold in the EU were adopted, which come into force in 2030. Many companies must now start replacing plastic, and BIO will hopefully be able to play a central role for several companies here going forward.
·9.7.My opinion is the following: Chemistry- A framework agreement has been signed and tests have been conducted where the end customer sells cosmetics. The purpose is to completely remove petroleum-based microplastics from these products. There will be EU regulations that are mandatory from 2027 to remove microplastics. The next step is a project agreement to introduce Bioextrax technology into Lipsticks; there are a lot of plastics in these products today. Candy- also a project that has been ongoing for several years. Gumbase for chewing gum contains approx. 20 % microplastic which is oil-based. Bioextraxt can replace this with its technology. The latest information is that a taste panel is testing finished products right now (should have been ready in Q2 2026). Unfortunately, this project has not kept to the schedule, but Bioextraxt has delivered its parts, so delays are due to Godis' internal processes. Lantmännen- A project is ongoing where Bioextraxt has produced approx. 100 Kg hydrolyzed protein, and Lantmännen has studied the feeding of Grisar and Fjäder with Djurfoder that contains this protein. The most unique aspect of this project is that the raw material in this project is Fjädrar from the poultry industry which is now only unusable waste. It is truly a win / Win in this project. Once the Djurfoder is approved, Lantmännen can introduce the technology and start selling this Djurfoder. There is very great potential in this project. Chematur- A factory has been sold by Chematur which is to be built. Planning is ongoing and if I remember correctly, the physical construction is to commence during the 2nd half of 2026. Bioextraxt will be paid for several years of production in advance, payment will probably not come until the factory is handed over to the customer. This first factory, which validates the technology, opens the door for several factory establishments. Generally, Bioextrax is the only company that can produce PHA without adding Kemikalier or Energi with its processes. What also makes this interesting is that they sell the license right to use their teiknik. Their own facility in Lund is only for creating product samples and helping customers with the establishment. In the examples above, customers must have sufficient material so that trial series of new end products can be created, tested, and approved.
This is partly correct, but the dates need clarification. According to EU Commission Regulation EU 2023/2055, which concerns intentionally added microplastics in products, it is not the case that all cosmetics must be free from microplastics from 2027. The dates differ depending on the product: 2027 primarily applies to rinse-off cosmetics, for example, shower gel, shampoo, and cleansing products. 2029 applies to many products that are left on the skin or hair, i.e., so-called leave-on products. However, lipstick, nail products, and make-up have a longer transition period. According to the EU Commission's guidance, the following applies there: 2031: products that still contain regulated microplastics must be labeled as containing microplastics. 2035: the last year to sell such products with regulated microplastics. So, if we are talking specifically about lipstick, it is a bit misleading to say that the rules force out microplastics already in 2027. For lipstick, the most important dates are rather 2031 and 2035.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
90 päivää sitten
‧35 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·4 t sittenThe CEO's message Formal start of the project with the customer in Western Asia In May, we announced that our partner, Chematur Engineering, had entered into a binding agreement with a customer in Western Asia regarding the first large-scale PHBV plant based on Bioextrax's patented technology. After the end of the second quarter, the customer made the agreed advance payment. The agreement has thereby entered into force, and Phase 1 – the basic design of the plant – has formally commenced. The work is estimated to take five months, and in parallel, the agreement for Phase 2, which includes detailed design, construction, and commissioning of the factory, is being finalized. Progress in the collaboration with Kemiföretaget Another important step was taken at the end of June, when we reached an agreement with Kemiföretaget – one of the world's three largest chemical companies – on a binding framework agreement. The agreement was signed at the beginning of July, runs for three years with the possibility of extension, and creates a clear structure for joint innovation and commercialization projects within Home & Personal Care. The first project concerns mcl-PHA as a bio-based and biodegradable film former that can replace, for example, silicone in personal care products. The driving force in the application is clear: the EU's restrictions against intentionally added microplastics mean that the industry needs alternatives that both function technically and degrade naturally. Strong interest in sun protection Within cosmetics, the sun protection track, which I wrote about in the previous report, has also been further developed. Our early results indicate that our PHBV has a better enhancing effect on SPF (sun protection factor, solskyddsfaktor) compared to PHA from other players, and this has continued to attract interest. Since the previous report, further dialogues and concrete tests have been initiated with global players. Sunscreen is an application that combines requirements from legislators, large volumes, and good willingness to pay, and we continue to evaluate it together with a growing circle of potential customers. Update on the project with Godisproducenten Regarding the collaboration with Godisproducenten, which aims to replace traditional polymers in chewing gums with biodegradable alternatives, we were recently informed that a major reorganization is underway within Godisproducenten. This, in turn, means that the test panel planned for the second quarter of 2026 has been delayed. Currently, we do not know when the test panel will be carried out. Ongoing production for Lantmännen In the project with Lantmännen, a large part of our work in recent months has focused on getting the entire production system in place – not just the hydrolysis step itself, which is the core of our technology, but also the downstream steps such as separation and drying. This is a prerequisite for being able to produce the quantities of hydrolyzed protein required by the feeding trials, and it has required significant resources to get all parts to work together. That work has now been completed. Our focus is therefore on finalizing production so that the material can proceed to feed mixing and feeding trials, together with Lantmännen. News regarding R&D In parallel with commercial development, we have developed a new technology for the production of PHBV, for which we have submitted a patent application. For natural reasons, we are not going into any details at this time, but we see significant potential in it and will revert when the patent situation allows. Continuously broadening and strengthening our intellectual property portfolio is central to a business model based on out-licensing. Ultimately, it is the patents that constitute the product we sell, and every new application that holds increases the value of what we have to offer future licensees. During the period, we have also installed our own laboratory for strain development and commenced work there. Strain development involves developing and refining the microorganisms that produce our PHA, and this gives us significantly greater flexibility – both to influence the material properties of the PHA produced and to adapt the process parameters in production. This opens up the possibility of meeting specific customer requirements in a way that would otherwise not have been possible. In parallel, we continue to develop our existing production processes based on so-called “wild bacteria”; the new laboratory complements this work, it does not replace it. Lund, August 20, 2026 Edvard Hall Managing Director
- ·14.8.The company is currently small, has few employees, but has groundbreaking technology. A breakthrough here means contracts that are enormously large in SEK compared to today's market value. The stock is a binary bet currently, where the value might halve if things continue to drag out, but where the upside is 5-10x when concrete agreements come. The first agreement with "Kemi-bolaget" should be right around the corner.Market worth at 100 million then you are relatively cautious with 5x on the upside. I don't think there's much downside either with valuation against market value, probably scraping the bottom. I don't foresee another 50% 7 days before an update on projects. Rather listen to the podcast, However, I'm not all in, only a relatively small position.
- ·13.8.https://open.spotify.com/episode/1jlEKFgYJBoZ6zgj9qbrKD https://open.spotify.com/episode/1jlEKFgYJBoZ6zgj9qbrKD New podcast episode with Edward today.
- ·13.8.Today, new rules for the packaging of goods sold in the EU were adopted, which come into force in 2030. Many companies must now start replacing plastic, and BIO will hopefully be able to play a central role for several companies here going forward.
- ·9.7.My opinion is the following: Chemistry- A framework agreement has been signed and tests have been conducted where the end customer sells cosmetics. The purpose is to completely remove petroleum-based microplastics from these products. There will be EU regulations that are mandatory from 2027 to remove microplastics. The next step is a project agreement to introduce Bioextrax technology into Lipsticks; there are a lot of plastics in these products today. Candy- also a project that has been ongoing for several years. Gumbase for chewing gum contains approx. 20 % microplastic which is oil-based. Bioextraxt can replace this with its technology. The latest information is that a taste panel is testing finished products right now (should have been ready in Q2 2026). Unfortunately, this project has not kept to the schedule, but Bioextraxt has delivered its parts, so delays are due to Godis' internal processes. Lantmännen- A project is ongoing where Bioextraxt has produced approx. 100 Kg hydrolyzed protein, and Lantmännen has studied the feeding of Grisar and Fjäder with Djurfoder that contains this protein. The most unique aspect of this project is that the raw material in this project is Fjädrar from the poultry industry which is now only unusable waste. It is truly a win / Win in this project. Once the Djurfoder is approved, Lantmännen can introduce the technology and start selling this Djurfoder. There is very great potential in this project. Chematur- A factory has been sold by Chematur which is to be built. Planning is ongoing and if I remember correctly, the physical construction is to commence during the 2nd half of 2026. Bioextraxt will be paid for several years of production in advance, payment will probably not come until the factory is handed over to the customer. This first factory, which validates the technology, opens the door for several factory establishments. Generally, Bioextrax is the only company that can produce PHA without adding Kemikalier or Energi with its processes. What also makes this interesting is that they sell the license right to use their teiknik. Their own facility in Lund is only for creating product samples and helping customers with the establishment. In the examples above, customers must have sufficient material so that trial series of new end products can be created, tested, and approved.This is partly correct, but the dates need clarification. According to EU Commission Regulation EU 2023/2055, which concerns intentionally added microplastics in products, it is not the case that all cosmetics must be free from microplastics from 2027. The dates differ depending on the product: 2027 primarily applies to rinse-off cosmetics, for example, shower gel, shampoo, and cleansing products. 2029 applies to many products that are left on the skin or hair, i.e., so-called leave-on products. However, lipstick, nail products, and make-up have a longer transition period. According to the EU Commission's guidance, the following applies there: 2031: products that still contain regulated microplastics must be labeled as containing microplastics. 2035: the last year to sell such products with regulated microplastics. So, if we are talking specifically about lipstick, it is a bit misleading to say that the rules force out microplastics already in 2027. For lipstick, the most important dates are rather 2031 and 2035.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 25.8. | 5 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 22.5. | ||
2025 Q4 -tulosraportti 24.2. | ||
2025 Q3 -tulosraportti 26.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 20.5.2025 |
2026 Q1 -tulosraportti
90 päivää sitten
‧35 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 25.8. | 5 päivää |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 22.5. | ||
2025 Q4 -tulosraportti 24.2. | ||
2025 Q3 -tulosraportti 26.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 | ||
2025 Q1 -tulosraportti 20.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- ·4 t sittenThe CEO's message Formal start of the project with the customer in Western Asia In May, we announced that our partner, Chematur Engineering, had entered into a binding agreement with a customer in Western Asia regarding the first large-scale PHBV plant based on Bioextrax's patented technology. After the end of the second quarter, the customer made the agreed advance payment. The agreement has thereby entered into force, and Phase 1 – the basic design of the plant – has formally commenced. The work is estimated to take five months, and in parallel, the agreement for Phase 2, which includes detailed design, construction, and commissioning of the factory, is being finalized. Progress in the collaboration with Kemiföretaget Another important step was taken at the end of June, when we reached an agreement with Kemiföretaget – one of the world's three largest chemical companies – on a binding framework agreement. The agreement was signed at the beginning of July, runs for three years with the possibility of extension, and creates a clear structure for joint innovation and commercialization projects within Home & Personal Care. The first project concerns mcl-PHA as a bio-based and biodegradable film former that can replace, for example, silicone in personal care products. The driving force in the application is clear: the EU's restrictions against intentionally added microplastics mean that the industry needs alternatives that both function technically and degrade naturally. Strong interest in sun protection Within cosmetics, the sun protection track, which I wrote about in the previous report, has also been further developed. Our early results indicate that our PHBV has a better enhancing effect on SPF (sun protection factor, solskyddsfaktor) compared to PHA from other players, and this has continued to attract interest. Since the previous report, further dialogues and concrete tests have been initiated with global players. Sunscreen is an application that combines requirements from legislators, large volumes, and good willingness to pay, and we continue to evaluate it together with a growing circle of potential customers. Update on the project with Godisproducenten Regarding the collaboration with Godisproducenten, which aims to replace traditional polymers in chewing gums with biodegradable alternatives, we were recently informed that a major reorganization is underway within Godisproducenten. This, in turn, means that the test panel planned for the second quarter of 2026 has been delayed. Currently, we do not know when the test panel will be carried out. Ongoing production for Lantmännen In the project with Lantmännen, a large part of our work in recent months has focused on getting the entire production system in place – not just the hydrolysis step itself, which is the core of our technology, but also the downstream steps such as separation and drying. This is a prerequisite for being able to produce the quantities of hydrolyzed protein required by the feeding trials, and it has required significant resources to get all parts to work together. That work has now been completed. Our focus is therefore on finalizing production so that the material can proceed to feed mixing and feeding trials, together with Lantmännen. News regarding R&D In parallel with commercial development, we have developed a new technology for the production of PHBV, for which we have submitted a patent application. For natural reasons, we are not going into any details at this time, but we see significant potential in it and will revert when the patent situation allows. Continuously broadening and strengthening our intellectual property portfolio is central to a business model based on out-licensing. Ultimately, it is the patents that constitute the product we sell, and every new application that holds increases the value of what we have to offer future licensees. During the period, we have also installed our own laboratory for strain development and commenced work there. Strain development involves developing and refining the microorganisms that produce our PHA, and this gives us significantly greater flexibility – both to influence the material properties of the PHA produced and to adapt the process parameters in production. This opens up the possibility of meeting specific customer requirements in a way that would otherwise not have been possible. In parallel, we continue to develop our existing production processes based on so-called “wild bacteria”; the new laboratory complements this work, it does not replace it. Lund, August 20, 2026 Edvard Hall Managing Director
- ·14.8.The company is currently small, has few employees, but has groundbreaking technology. A breakthrough here means contracts that are enormously large in SEK compared to today's market value. The stock is a binary bet currently, where the value might halve if things continue to drag out, but where the upside is 5-10x when concrete agreements come. The first agreement with "Kemi-bolaget" should be right around the corner.Market worth at 100 million then you are relatively cautious with 5x on the upside. I don't think there's much downside either with valuation against market value, probably scraping the bottom. I don't foresee another 50% 7 days before an update on projects. Rather listen to the podcast, However, I'm not all in, only a relatively small position.
- ·13.8.https://open.spotify.com/episode/1jlEKFgYJBoZ6zgj9qbrKD https://open.spotify.com/episode/1jlEKFgYJBoZ6zgj9qbrKD New podcast episode with Edward today.
- ·13.8.Today, new rules for the packaging of goods sold in the EU were adopted, which come into force in 2030. Many companies must now start replacing plastic, and BIO will hopefully be able to play a central role for several companies here going forward.
- ·9.7.My opinion is the following: Chemistry- A framework agreement has been signed and tests have been conducted where the end customer sells cosmetics. The purpose is to completely remove petroleum-based microplastics from these products. There will be EU regulations that are mandatory from 2027 to remove microplastics. The next step is a project agreement to introduce Bioextrax technology into Lipsticks; there are a lot of plastics in these products today. Candy- also a project that has been ongoing for several years. Gumbase for chewing gum contains approx. 20 % microplastic which is oil-based. Bioextraxt can replace this with its technology. The latest information is that a taste panel is testing finished products right now (should have been ready in Q2 2026). Unfortunately, this project has not kept to the schedule, but Bioextraxt has delivered its parts, so delays are due to Godis' internal processes. Lantmännen- A project is ongoing where Bioextraxt has produced approx. 100 Kg hydrolyzed protein, and Lantmännen has studied the feeding of Grisar and Fjäder with Djurfoder that contains this protein. The most unique aspect of this project is that the raw material in this project is Fjädrar from the poultry industry which is now only unusable waste. It is truly a win / Win in this project. Once the Djurfoder is approved, Lantmännen can introduce the technology and start selling this Djurfoder. There is very great potential in this project. Chematur- A factory has been sold by Chematur which is to be built. Planning is ongoing and if I remember correctly, the physical construction is to commence during the 2nd half of 2026. Bioextraxt will be paid for several years of production in advance, payment will probably not come until the factory is handed over to the customer. This first factory, which validates the technology, opens the door for several factory establishments. Generally, Bioextrax is the only company that can produce PHA without adding Kemikalier or Energi with its processes. What also makes this interesting is that they sell the license right to use their teiknik. Their own facility in Lund is only for creating product samples and helping customers with the establishment. In the examples above, customers must have sufficient material so that trial series of new end products can be created, tested, and approved.This is partly correct, but the dates need clarification. According to EU Commission Regulation EU 2023/2055, which concerns intentionally added microplastics in products, it is not the case that all cosmetics must be free from microplastics from 2027. The dates differ depending on the product: 2027 primarily applies to rinse-off cosmetics, for example, shower gel, shampoo, and cleansing products. 2029 applies to many products that are left on the skin or hair, i.e., so-called leave-on products. However, lipstick, nail products, and make-up have a longer transition period. According to the EU Commission's guidance, the following applies there: 2031: products that still contain regulated microplastics must be labeled as containing microplastics. 2035: the last year to sell such products with regulated microplastics. So, if we are talking specifically about lipstick, it is a bit misleading to say that the rules force out microplastics already in 2027. For lipstick, the most important dates are rather 2031 and 2035.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt